• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

20 Promising Canadian Digital Health Companies to Watch

by Komal Garewal 07/08/2015 Leave a Comment

6. Memotext

logo-memotext

Memotext’s solutions for medication adherence are based on flexible algorithms that influence behavior change by adapting to each patient’s changing biometrics and collected circumstances. Programs are also customizable by physicians or brands to enhance effectiveness of the platform for each specific user or cohort. Not only can this boost a provider’s reported quality of care measures and reimbursement rates (depending on the country’s policy), but also a drug’s efficacy rating.

Founded: Unknown

Founders: Amos Adler (CEO)

Category: Patient Adherence

Funding: Undisclosed

Why you should pay attention – Their randomized clinical trial shows a 17% increase in patients’ confidence of self-management, up to a 55% improvement in patients’ medication possession ratio and an increase of 88% in user retention. Client testimonials cite that better patient adherence equates to better patient outcomes and higher patient satisfaction for the provider.

7. Myndtec

myndmove

Redefining neurorehab, Myndtec develops and commercializes innovative medical devices and therapies designed to improve function, maximize independence and enhance quality of life. Their first product, MyndMove, is a proprietary eight-channel Functional Electrical Stimulation (FES) device that assists patients in recovering natural and voluntary movements in the arms or hands after suffering from paralysis, stroke or spinal cord injury.

Founded: 2008 (previously Simple Systems)

Founders: Milos Popovic, M.D. & Aleksandar Prodic, M.D.

Category: Diagnostics, Technology & Treatment

Funding: Undisclosed

Why you should pay attention – The proprietary FES device can also be used in the rehabilitation and treatment of neuromuscular conditions. While the device is to be used in conjunction with a physical therapist’s expertise, if the device is eventually sold direct-to-consumers (or to in-home caregivers), adherence to treatment may be improved while simultaneously decreasing recovery time.

8. NerveVision

nervevision

This patent-pending, FDA-cleared diagnostic support platform can reconstruct 3D images of any peripheral nerve taken in a standard MRI series allowing clinicians to more easily locate, see and assess abnormalities. The NerveVision technology introduces new methods of understanding nerve disorders and lets physicians develop more comprehensive and detailed plans for pain management, as well as direct interventions in pre-surgical planning.

Founded: Unknown

Founders: Lionel Lenkinski, M.D., Jay Freeman & Domenico Ciambrone

Category: Diagnostics & Technology

Funding: Undisclosed

Why you should pay attention – The greater accuracy and detail NerveVision lends to diagnostics and treatment assessments can reduce the number of procedures patients must undergo, overall treatment costs and opportunity costs associated with time spent in medical settings. The technology also has the ability to make patient visits more efficient and meaningful, and it has been implemented at some of the most prestigious institutions in the U.S. including Massachusetts General & Johns Hopkins.

9. Oxalys Pharmaceuticals

Oxalys Pharma

Specializing in neurodegeneration therapeutics, Oxalys is developing therapies that prevent, slow or reverse the process of brain degeneration. The drug discovery platform aims to target the underlying cause of such conditions and has been designed to identify the molecules that suppress the toxic effect of mutations that cause degeneration. Their lead therapeutic, OXD-4, reduces the harmful effects of stress on the brain and prevents neurons from excitotoxic cell death.

Founded: 2011

Founders: Katharine Sepp (CEO)

Category: Diagnostics & Treatment

Funding: Undisclosed

Why you should pay attention – Capitalizing on the robust pharmaceutical market, the company has been testing drugs already in circulation to assess their potential efficacy on neurodegenerative conditions. Repurposing such medications is not only cost-effective, but can speed up the approval time for clinical trials, as it has done for OXD-4.

10. Seamless MD

seamless md

A patient education and engagement platform, Seamless MD prepares people for upcoming surgeries with pre- and post-op care information, medication reminders, interactive care plans and tools for self-management. The platform also collects data and transmits it to the appropriate caregiver making those providers who use it eligible for certain reimbursement requirements (depending on the country).

Founded: Unknown

Founders: Joshua Liu, Philip Chen & Willie Kwok

Category: Patient Adherence & Treatment

Funding: Undisclosed

Why you should pay attention – Named a Forbes 30 Under 30 in Healthcare and one of the top 20 hottest innovation companies in Canada by CIX, the platform can lower the risk of readmission and post-op complications thereby increasing provider availability for other patients. As specialists in Canada already have extremely long waiting lists, this has the potential to decrease wait times for appointments, as well as between diagnosis and treatment.

Pages: Page 1 Page 2 Page 3 Page 4

Tagged With: algorithms, API, Asthma, behavior, big data, Biometric Data, cancer, Caregivers, Catalyze, Circulation, Clinical Trial, Clinical Trial Recruitment, Clinical Trials, COPD, data analytics, decision support, dementia, diabetes, digital health, dna, DNA Testing, Doximity, Drug Discovery, Evidence-based medicine, Facebook, FDA, Figure 1, genomics, google, Google Glass, health insurance, Health Startups, Health Systems, Health Tech Startups, Healthfundr, Heart, heart disease, HIT, Home Care, In-Home Care, intel, Interface Health, Kaiser Permanente, MD, Medical Device, Medical Devices, medication, Medication Adherence, Mental Health, mhealth, mobile health, Notable, Novartis, Pain Management, Patient Adherence, Patient Care, Patient Education, patient engagement, Patient Monitoring, Patient Satisfaction, Personal Health Record, Personalized Medicine, physicians, Population Health, Public Health, remote patient monitoring, Sanofi, sensors, Software Development Kit, telehealth, venture capital, Wireless Sensors, workplace

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Komal Garewal

by Komal Garewal

Komal Garewal is the former Head of Operations & Client Services at MedStartr, the first healthcare crowdfunding platform where she advised startup founders on project optimization, business and product development, marketing strategies, and scaling up methods. She has worked on over 75 crowdfunding projects, which have appeared on platforms ranging from Indiegogo to RocketHub raising over $400k in funding to date.

Like this article? Share it!

  •  
  •  
  •  
  •  
  •  

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |